
AIIMS Delhi recalled certain batches of disposable syringes earlier this year after user departments reported quality complaints, Union Health Minister of State Prataprao Jadhav told the Rajya Sabha on 5 August 2026. The syringes were manufactured by Noble Pharmacare and Veekay Surgicals. No adverse effects on patients were reported.
The affected stock was replaced and show-cause notices were issued to both companies. AIIMS said it uses random sampling, bid-sample comparisons and checks to reject non-conforming batches. The Ministry did not disclose the defects, test results or number of batches withdrawn. AIIMS has a Patient Safety and Quality Cell for investigations.
The recall and replacement indicate that officials responded cautiously, while the reported absence of patient harm is reassuring. However, the limited public information makes it difficult to judge the seriousness of the defects. Claims that the syringes were dangerous would be premature, but dismissing the complaints would also be unwise. Clear technical findings would help patients and medical staff assess the matter without speculation.
Source: thehindu.com
This story was synthesised by AI from the source linked above.